{"resourceType":"Bundle","id":"tests-33bba852-de31-46c0-a0fd-1439cf733ad7-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/33bba852-de31-46c0-a0fd-1439cf733ad7","resource":{"resourceType":"Patient","id":"33bba852-de31-46c0-a0fd-1439cf733ad7","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"6298e96c5c5f0f80c3806878"}],"name":[{"family":"DENOMFail","given":["LastStagingAfter1stTreatment"]}],"gender":"male","birthDate":"1979-12-31"},"request":{"method":"PUT","url":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"0deefb7c-506b-41cb-936c-40e5b7022890","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"},{"system":"http://snomed.info/sct","code":"439401001","display":"Diagnosis"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"onsetPeriod":{"start":"2007-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/0deefb7c-506b-41cb-936c-40e5b7022890"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"559417b9-af3e-48d4-b5ba-4081e001e159","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"performedDateTime":"2025-08-25T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/559417b9-af3e-48d4-b5ba-4081e001e159"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8db","resource":{"resourceType":"Observation","id":"4646d8ee-583c-4cc3-9d3d-f4516e976754","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"2857-1","display":"Prostate specific Ag [Mass/volume] in Serum or Plasma","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-04-24T08:00:00.000+00:00","valueQuantity":{"value":8.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/4646d8ee-583c-4cc3-9d3d-f4516e976754"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"0e8997a3-bfc0-4051-b0c0-1080bccd41ec","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-01-02T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/0e8997a3-bfc0-4051-b0c0-1080bccd41ec"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"a21f4fc6-d9c2-4320-88e6-9bc28b388ec8","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-04-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"Neoplasm of prostate primary tumor staging category T2a: Involves one-half of one lobe or less (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/a21f4fc6-d9c2-4320-88e6-9bc28b388ec8"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a9dd","resource":{"resourceType":"Observation","id":"1fa93bab-d613-45c3-a633-263cf8905718","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-06-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"T1a: Prostate tumor incidental histologic finding in 5 percent or less of tissue resected (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/1fa93bab-d613-45c3-a633-263cf8905718"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a10dd","resource":{"resourceType":"Observation","id":"98ec2d00-a008-48eb-b447-be647dca43e6","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-12-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"T1b: Prostate tumor incidental histologic finding in greater than 5 percent of tissue resected (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/98ec2d00-a008-48eb-b447-be647dca43e6"}},{"fullUrl":"https://madie.cms.gov/Observation/bone-scan-5337","resource":{"resourceType":"Observation","id":"0f4f58f0-7fdf-4552-b854-64b85a461303","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"25031-6","display":"NM Bone Views","userSelected":true}]},"subject":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","issued":"2025-08-17T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Observation/0f4f58f0-7fdf-4552-b854-64b85a461303"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"4361b27b-f56b-44ab-8113-4cbc75647a99","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/33bba852-de31-46c0-a0fd-1439cf733ad7"},"payor":[{"reference":"Organization/84b56847-ad40-4bf6-b612-9e42ad2a84e5"}]},"request":{"method":"PUT","url":"Coverage/4361b27b-f56b-44ab-8113-4cbc75647a99"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"84b56847-ad40-4bf6-b612-9e42ad2a84e5","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/84b56847-ad40-4bf6-b612-9e42ad2a84e5"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"3d2eeff6-0bfd-4034-a59c-4bae6052868e","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/3d2eeff6-0bfd-4034-a59c-4bae6052868e"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/340ee861-7d45-405a-99dc-d94807213738","resource":{"resourceType":"MeasureReport","id":"340ee861-7d45-405a-99dc-d94807213738","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"344a228c-8655-40be-bfac-3b4d5d9359ba-parameters","parameter":[{"name":"subject","valueString":"33bba852-de31-46c0-a0fd-1439cf733ad7"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#344a228c-8655-40be-bfac-3b4d5d9359ba-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Last staging occurred after the 1st treatment.  Last staging (12/26)  in MP was after treatment (8/25) but a staging was done before the treatment.  This meets intent and passes. "}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/340ee861-7d45-405a-99dc-d94807213738"}}]}